Spots Global Cancer Trial Database for Wide Excision Alone as Treatment for Ductal Carcinoma in Situ of The Breast

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Wide Excision Alone as Treatment for Ductal Carcinoma in Situ of The Breast

Official Title: Wide Excision Alone for DCIS-Grades 1 and 2

Study ID: NCT00165256

Conditions

Ductal Carcinoma in Situ of the Breast

Interventions

Observation

Study Description

Brief Summary: The purpose of this study is to determine if wide excision (surgical removal) alone is adequate treatment for small, grade 1 or 2 ductal carcinoma in situ (DCIS) of the breast.

Detailed Description: * Patients with DCIS are usually treated with the combination of breast-conserving surgery and radiation therapy or breast-conserving surgery alone. The purpose of this study is to evaluate whether localized low- or intermediate-grade DCIS, diagnosed with modern mammography and careful pathologic evaluation, could be treated with wide excision alone (omission of radiation therapy) and result in acceptably low local recurrence rates. * Follow-up consists of physical examinations at least every 6 months by the surgeon or radiation oncologist. Mammograms of the affected breast will be obtained every 6 months for 5 years and then annually. Mammograms of the unaffected breast will be performed annually.